1415798-41-2

Upstream product

• 864244-74-6 4-(4-amino-2-fluorophenoxy)pyridin-2-amine 
• 1415797-96-4 7-(4-fluorophenyl)-1-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridine-5-formic acid 
• 5334-41-8 5-amino-4-cyano-1-methylpyrazole 
• 62564-90-3 5-amino-1-methyl-1H-pyrazole-4-carbaldehyde 
• 1415797-94-2 ethyl 1-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridine-5-formate 
• 1415797-95-3 ethyl 7-(4-fluorophenyl1)-1-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridine-5-formate 

Relevant academic research and scientific papers

HETEROCYCLIC PYRIDONE COMPOUND, AND INTERMEDIATE, PREPARATION METHOD AND USE THEREOF

The present invention relates to a heterocyclic pyridone compound represented by General Formula (I), where the heterocyclic pyridone compound is used as a tyrosine kinase inhibitor, and particularly a c-Met inhibitor. The present invention also relates to intermediates for preparing heterocyclic pyridone compound and a preparation method. The present invention further relates to a pharmaceutical composition containing the heterocyclic pyridone compound as an active ingredient, and a use of the pharmaceutical composition in treatment of diseases associated with tyrosine kinase c-Met, especially cancer associated with c-Met, as a medicament.